Differentiated human SHSY5Y cells provide a reductionist model of herpes simplex virus 1 neurotropism

Journal of Virology

Volumn 91, Issue 23, 2017, Pages

  Shipley, Mackenzie M ^a   Mangold, Colleen A ^a   Kuny, Chad V ^a   Szpara, Moriah L ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

CGAS; Differentiation; Herpes simplex virus; HSV 1; Infection; Neuron; SH SY5Y; SK N SH; Virus

Indexed keywords

CELL MARKER; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT HEAVY CHAIN PROTEIN; NEUROFILAMENT PROTEIN; NEUROMODULIN; PROCASPASE 3; PROTEIN KINASE B; SYNAPTIC VESICLE PROTEIN 2; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; MB21D1 PROTEIN, HUMAN; NUCLEOTIDYLTRANSFERASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; AXON; CELL NUCLEUS; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HERPES SIMPLEX; HUMAN; HUMAN ALPHAHERPESVIRUS 1; HUMAN CELL; MRC-5 CELL LINE; NERVE CELL DIFFERENTIATION; NEURITE; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SH-SY5Y CELL LINE; VERO CELL LINE; VIRUS CELL INTERACTION; VIRUS RELEASE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; GENETICS; NERVE CELL; NEUROBLASTOMA; PHYSIOLOGY; TUMOR CELL LINE; VIRAL TROPISM; VIROLOGY;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; HERPESVIRUS 1, HUMAN; HUMANS; NEUROBLASTOMA; NEURONS; NUCLEOTIDYLTRANSFERASES; VIRAL TROPISM; VIRUS REPLICATION;

EID: 85033790223     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00958-17     Document Type: Article

References (163)

1. Roizman B, Knipe DM, Whitley R. 2013. Herpes simplex viruses, p 1823-1897. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA
2. Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Gottlieb SL, Newman LM. 2015. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One 10:e014065. https://doi.org/10.1371/journal.pone.0140765
3. Looker KJ, Magaret AS, Turner KME, Vickerman P, Gottlieb SL, Newman LM. 2015. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One 10:e114989. https://doi.org/10.1371/journal.pone.0114989
4. Thompson RL, Preston CM, Sawtell NM. 2009. De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoS Pathog 5:e1000352. https://doi.org/10.1371/journal.ppat.1000352
5. Wilson AC, Mohr I. 2012. A cultured affair: HSV latency and reactivation neurons. Trends Microbiol 20:604-611. https://doi.org/10.1016/j.tim.2012.08.005
6. Bloom DC. 2016. Alphaherpesvirus latency: a dynamic state of transcription and reactivation. Adv Virus Res 94:53-80. https://doi.org/10.1016/bs.aivir.2015.10.001
7. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW. 1999 Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med 189:663-672. https://doi.org/10.1084/jem.189.4.663
8. Dix RD, McKendall RR, Baringer JR. 1983. Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun 40:103-112
9. Whitley RJ, Kimberlin DW, Roizman B. 1998. Herpes simplex viruses. Clin Infect Dis 26:541-555. https://doi.org/10.1086/514600
10. Knipe DM, Cliffe A. 2008. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 6:211-221. https://doi.org/10.1038/nrmicro1794
11. Menachery VD, Pasieka TJ, Leib DA. 2010. Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J Virol 84:9685-9694. https://doi.org/10.1128/JVI.00706-10
12. Kumar H, Kawai T, Akira S. 2011. Pathogen recognition by the innate immune system. Int Rev Immunol 30:16-34. https://doi.org/10.3109/08830185.2010.529976
13. Sasai M, Yamamoto M. 2013. Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors. Int Rev Immunol 32: 116-133. https://doi.org/10.3109/08830185.2013.774391
14. Burdette DL, Vance RE. 2013. STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol 14:19-26. https://doi.org/10.1038/ni.2491
15. Orzalli MH, DeLuca NA, Knipe DM. 2012. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A 109:E3008-E3017. https://doi.org/10.1073/pnas.1211302109
16. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791. https://doi.org/10.1126/science.1232458
17. Li X-D, Wu J, Gao D, Wang H, Sun L, Chen ZJ. 2013. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341:1390-1394. https://doi.org/10.1126/science.1244040
18. Thompson MR, Sharma S, Atianand M, Jensen SB, Carpenter S, Knipe DM, Fitzgerald KA, Kurt-Jones EA. 2014. Interferon-inducible protein (IFI) 16 transcriptionally regulates type I interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses. J Biol Chem 289:23568-23581. https://doi.org/10.1074/jbc.M114.554147
19. Diner BA, Lum KK, Javitt A, Cristea IM. 2015. Interactions of the antiviral factor interferon gamma-inducible protein 16 (IFI16) mediate immune signaling and herpes simplex virus-1 immunosuppression. Mol Cell Proteomics 14:2341-2356. https://doi.org/10.1074/mcp.M114.047068
20. Orzalli MH, Broekema NM, Diner BA, Hancks DC, Elde NC, Cristea IM, Knipe DM. 2015. cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection. Proc Natl Acad Sci U S A 112:E1773-E1781. https://doi.org/10.1073/pnas.1424637112
21. Chen Q, Sun L, Chen ZJ. 2016. Regulation and function of the cGASSTING pathway of cytosolic DNA sensing. Nat Immunol 17:1142-1149. https://doi.org/10.1038/ni.3558
22. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320-4330. https://doi.org/10.4049/jimmunol.175.7.4320
23. Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013-1021. https://doi.org/10.1093/jnen/61.11.1013
24. Lafon M, Megret F, Lafage M, Prehaud C. 2006. The innate immune facet of brain. J Mol Neurosci 29:185-194. https://doi.org/10.1385/JMN:29:3:185
25. Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku C-L, Casrouge A, Zhang X-X, Barreiro L, Leonard J, Hamilton C, Lebon P, Heron B, Vallee L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova J-L. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527. https://doi.org/10.1126/science.1139522
26. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366-1373. https://doi.org/10.1038/nm1140
27. Boulanger LM, Shatz CJ. 2004. Immune signalling in neural development, synaptic plasticity and disease. Nat Rev Neurosci 5:521-531. https://doi.org/10.1038/nrn1428
28. VanGuilder Starkey HD, Van Kirk CA, Bixler GV, Imperio CG, Kale VP, Serfass JM, Farley JA, Yan H, Warrington JP, Han S, Mitschelen M, Sonntag WE, Freeman WM. 2012. Neuroglial expression of the MHCI pathway and PirB receptor is upregulated in the hippocampus with advanced aging. J Mol Neurosci 48:111-126. https://doi.org/10.1007/s12031-012-9783-8
29. Redwine JM, Buchmeier MJ, Evans CF. 2001. In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am J Pathol 159:1219-1224. https://doi.org/10.1016/S0002-9440(10)62507-2
30. Pereira RA, Tscharke DC, Simmons A. 1994. Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J Exp Med 180:841-841. https://doi.org/10.1084/jem.180.3.841
31. Markus A, Grigoryan S, Sloutskin A, Yee MB, Zhu H, Yang IH, Thakor NV, Sarid R, Kinchington PR, Goldstein RS. 2011. Varicella-zoster virus (VZV) infection of neurons derived from human embryonic stem cells: direct demonstration of axonal infection, transport of VZV, and productive neuronal infection. J Virol 85:6220-6233. https://doi.org/10.1128/JVI.02396-10
32. De Regge N, Favoreel HW, Geenen K, Nauwynck HJ. 2006. A homologous in vitro model to study interactions between alphaherpesviruses and trigeminal ganglion neurons. Vet Microbiol 113:251-255. https://doi.org/10.1016/j.vetmic.2005.11.004
33. Trousdale MD, Steiner I, Spivack JG, Deshmane SL, Brown SM, MacLean AR, Subak-Sharpe JH, Fraser NW. 1991. In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J Virol 65:6989-6993
34. Kobayashi M, Kim J-Y, Camarena V, Roehm PC, Chao MV, Wilson AC, Mohr I. 2012. A primary neuron culture system for the study of herpes simplex virus latency and reactivation. J Vis Exp 2012 (62):3823
35. Brodeur GM, Sekhon G, Goldstein MN. 1977. Chromosomal aberrations in human neuroblastomas. Cancer 40:2256-2263. https://doi.org/10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1
36. Hu B-Y, Weick JP, Yu J, Ma L-X, Zhang X-Q, Thomson JA, Zhang S-C. 2010 Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 107:4335-4340. https://doi.org/10.1073/pnas.0910012107
37. Cheng Y, Ma Z, Kim B-H, Wu W, Cayting P, Boyle AP, Sundaram V, Xing X, Dogan N, Li J, Euskirchen G, Lin S, Lin Y, Visel A, Kawli T, Yang X, Patacsil D, Keller CA, Giardine B, The Mouse ENCODE Consortium, Kundaje A, Wang T, Pennacchio LA, Weng Z, Hardison RC, Snyder MP. 2014 Principles of regulatory information conservation between mouse and human. Nature 515:371-375. https://doi.org/10.1038/nature13985
38. Lin S, Lin Y, Nery JR, Urich MA, Breschi A, Davis CA, Dobin A, Zaleski C, Beer MA, Chapman WC, Gingeras TR, Ecker JR, Snyder MP. 2014. Comparison of the transcriptional landscapes between human and mouse tissues. Proc Natl Acad Sci U S A 111:17224-17229. https://doi.org/10.1073/pnas.1413624111
39. Odom DT, Dowell RD, Jacobsen ES, Gordon W, Danford TW, MacIsaac KD, Rolfe PA, Conboy CM, Gifford DK, Fraenkel E. 2007. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nat Genet 39:730-732. https://doi.org/10.1038/ng2047
40. McGeoch DJ, Cook S. 1994. Molecular phylogeny of the alphaherpesvirinae subfamily and a proposed evolutionary timescale. J Mol Biol 238:9-22
41. Whitley RJ. 2006. Herpes simplex encephalitis: adolescents and adults. Antiviral Res 71:141-148. https://doi.org/10.1016/j.antiviral.2006.04.002
42. Whitley RJ. 2015. Herpes simplex virus infections of the central nervous system. Contin Lifelong Learn Neurol 21:1704-1713. https://doi.org/10.1212/CON.0000000000000243
43. Sancho-Shimizu V, Zhang S-Y, Abel L, Tardieu M, Rozenberg F, Jouanguy E, Casanova J-L. 2007. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans. Curr Opin Allergy Clin Immunol 7:495-505. https://doi.org/10.1097/ACI.0b013e3282f151d2
44. Kastrukoff LF, Lau AS, Thomas EE. 2012. The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS). Herpesviridae 3:4. https://doi.org/10.1186/2042-4280-3-4
45. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Ceña V, Gallego C, Comella JX. 2000. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75:991-1003. https://doi.org/10.1046/j.1471-4159.2000.0750991.x
46. Christensen J, Steain M, Slobedman B, Abendroth A. 2011. Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells. J Virol 85:8436-8442. https://doi.org/10.1128/JVI.00515-11
47. Biedler JL, Helson L, Spengler BA. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652
48. Gimenez-Cassina A, Lim F, Diaz-Nido J. 2006. Differentiation of a human neuroblastoma into neuron-like cells increases their susceptibility to transduction by herpesviral vectors. J Neurosci Res 84:755-767. https://doi.org/10.1002/jnr.20976
49. Allsopp TE, McLuckie J, Kerr LE, Macleod M, Sharkey J, Kelly JS. 2000. Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ 7:984-993. https://doi.org/10.1038/sj.cdd.4400733
50. Schamberger CJ, Gerner C, Cerni C. 2005. Caspase-9 plays a marginal role in serum starvation-induced apoptosis. Exp Cell Res 302:115-128. https://doi.org/10.1016/j.yexcr.2004.08.026
51. Pa°hlman S, Hoehner JC, Nånberg E, Hedborg F, Fagerström S, Gestblom C, Johansson I, Larsson U, Lavenius E, örtoft E, Söderholm H. 1995. Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31:453-458. https://doi.org/10.1016/0959-8049(95)00033-F
52. Patapoutian A, Reichardt LF. 2001. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11:272-280. https://doi.org/10.1016/S0959-4388(00)00208-7
53. Shipley MM, Mangold CA, Szpara ML. 2016. Differentiation of the SH-SY5Y human neuroblastoma cell line. J Vis Exp 2016 (108):e53193
54. Yang M-R, Lee SR, Oh W, Lee E-W, Yeh J-Y, Nah J-J, Joo Y-S, Shin J, Lee H-W, Pyo S, Song J. 2008. West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. Cell Microbiol 10:165-176. https://doi.org/10.1111/j.1462-5822.2007.01081.x
55. La Monica N, Racaniello VR. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J Virol 63:2357-2360
56. Castorena KM, Peltier DC, Peng W, Miller DJ. 2008. Maturationdependent responses of human neuronal cells to western equine encephalitis virus infection and type I interferons. Virology 372: 208-220. https://doi.org/10.1016/j.virol.2007.10.025
57. Irwin DJ, Wunner WH, Ertl HC, Jackson AC. 1999. Basis of rabies virus neurovirulence in mice: expression of major histocompatibility complex class I and class II mRNAs. J Neurovirol 5:485-494. https://doi.org/10.3109/13550289909045377
58. Constantinescu R, Constantinescu AT, Reichmann H, Janetzky B. 2007. Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y. J Neural Transm Suppl 72:17-28. https://doi.org/10.1007/978-3-211-73574-9_3
59. Cheung Y-T, Lau WK-W, Yu M-S, Lai CS-W, Yeung S-C, So K-F, Chang RC-C. 2009. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30:127-135. https://doi.org/10.1016/j.neuro.2008.11.001
60. Nixon Ralph A, Sihag Ram K. 1991. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci 14:501-506
61. Nowack A, Yao J, Custer KL, Bajjalieh SM. 2010. SV2 regulates neurotransmitter release via multiple mechanisms. Am J Physiol Cell Physiol 299:C960-C967. https://doi.org/10.1152/ajpcell.00259.2010
62. Benowitz LI, Routtenberg A. 1987. A membrane phosphoprotein associated with neural development, axonal regeneration, phospholipid metabolism, and synaptic plasticity. Trends Neurosci 10:527-531. https://doi.org/10.1016/0166-2236(87)90135-4
63. Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. 1986. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci U S A 83:3500-3504. https://doi.org/10.1073/pnas.83.10.3500
64. Reference deleted
65. Camarena V, Kobayashi M, Kim JY, Roehm P, Perez R, Gardner J, Wilson AC, Mohr I, Chao MV. 2010. Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. Cell Host Microbe 8:320-330. https://doi.org/10.1016/j.chom.2010.09.007
66. Ma Z, Damania B. 2016. The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe 19:150-158. https://doi.org/10.1016/j.chom.2016.01.010
67. Williams LE, Nesburn AB, Kaufman HE. 1965. Experimental induction of disciform keratitis. Arch Ophthalmol 73:112-114. https://doi.org/10.1001/archopht.1965.00970030114023
68. Hill JM, Rayfield MA, Haruta Y. 1987. Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res 6:91-97. https://doi.org/10.3109/02713688709020074
69. Wang H, Davido DJ, Morrison LA. 2013. HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice. Virus Res 173:436-440. https://doi.org/10.1016/j.virusres.2013.01.001
70. Sedarati F, Stevens JG. 1987. Biological basis for virulence of three strains of herpes simplex virus type 1. J Gen Virol 68:2389-2395. https://doi.org/10.1099/0022-1317-68-9-2389
71. Khodarev NN, Advani SJ, Gupta N, Roizman B, Weichselbaum RR. 1999. Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc Natl Acad Sci U S A 96:12062-12067. https://doi.org/10.1073/pnas.96.21.12062
72. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274-277. https://doi.org/10.1126/science.1833819
73. Franke TF, Yang S, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. 1995. The protein kinase encoded by the akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736. https://doi.org/10.1016/0092-8674(95)90534-0
74. Qiao J, Paul P, Lee S, Qiao L, Josifi E, Tiao JR, Chung DH. 2012. PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation. Biochem Biophys Res Commun 424:421-426. https://doi.org/10.1016/j.bbrc.2012.06.125
75. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ. 1993. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differ-entiation of human neuroblastoma cells. Neuron 11:321-331. https://doi.org/10.1016/0896-6273(93)90187-V
76. Benetti L, Roizman B. 2006. Protein kinase B/Akt is present in activated form throughout the entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with wild-type herpes simplex virus 1. J Virol 80:3341-3348. https://doi.org/10.1128/JVI.80.7.3341-3348.2006
77. Cheshenko N, Trepanier JB, Stefanidou M, Buckley N, Gonzalez P, Jacobs W, Herold BC. 2013. HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression. FASEB J 27:2584-2599. https://doi.org/10.1096/fj.12-220285
78. Liu X, Cohen JI. 2015. The role of PI3K/Akt in human herpesvirus infection: from the bench to the bedside. Virology 479-480:568-577
79. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997 Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241. https://doi.org/10.1016/S0092-8674(00)80405-5
80. Manning BD, Cantley LC. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261-1274. https://doi.org/10.1016/j.cell.2007.06.009
81. Kaur S, Sassano A, Dolniak B, Joshi S, Majchrzak-Kita B, Baker DP, Hay N, Fish EN, Platanias LC. 2008. Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci U S A 105: 4808-4813. https://doi.org/10.1073/pnas.0710907105
82. Buchkovich NJ, Yu Y, Zampieri CA, Alwine JC. 2008. The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nat Rev Microbiol 6:266-275. https://doi.org/10.1038/nrmicro1855
83. Tiwari V, Shukla D. 2010. Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry. J Gen Virol 91:3002-3009. https://doi.org/10.1099/vir.0.024166-0
84. Kobayashi M, Wilson AC, Chao MV, Mohr I. 2012. Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor. Genes Dev 26:1527-1532. https://doi.org/10.1101/gad.190157.112
85. Chuluunbaatar U, Mohr I. 2011. A herpesvirus kinase that masquerades as Akt: you don't have to look like Akt, to act like it. Cell Cycle 10:2064-2068. https://doi.org/10.4161/cc.10.13.16242
86. Tao J, Zhou X, Jiang Z. 2016. cGAS-cGAMP-STING: the three musketeers of cytosolic DNA sensing and signaling: cytosolic DNA sensing and signaling. IUBMB Life 68:858-870. https://doi.org/10.1002/iub.1566
87. Seo GJ, Yang A, Tan B, Kim S, Liang Q, Choi Y, Yuan W, Feng P, Park H-S, Jung JU. 2015. Akt kinase-mediated checkpoint of cGAS DNA sensing pathway. Cell Rep 13:440-449. https://doi.org/10.1016/j.celrep.2015.09.007
88. Sawtell NM, Poon DK, Tansky CS, Thompson RL. 1998. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol 72: 5343-5350
89. Luker KE, Schultz T, Romine J, Leib DA, Luker GD. 2006. Transgenic reporter mouse for bioluminescence imaging of herpes simplex virus 1 infection in living mice. Virology 347:286-295. https://doi.org/10.1016/j.virol.2005.12.016
90. Lyman MG, Kemp CD, Taylor MP, Enquist LW. 2009. Comparison of the pseudorabies virus Us9 protein with homologs from other veterinary and human alphaherpesviruses. J Virol 83:6978-6986. https://doi.org/10.1128/JVI.00598-09
91. Negatsch A, Mettenleiter TC, Fuchs W. 2011. Herpes simplex virus type 1 strain KOS carries a defective US9 and a mutated US8A gene. J Gen Virol 92:167-172. https://doi.org/10.1099/vir.0.026484-0
92. Howard PW, Howard TL, Johnson DC. 2013. Herpes simplex virus membrane proteins gE/gI and US9 act cooperatively to promote transport of capsids and glycoproteins from neuron cell bodies into initial axon segments. J Virol 87:403-414. https://doi.org/10.1128/JVI.02465-12
93. Sawtell NM, Thompson RL. 2016. De novo herpes simplex virus VP16 expression gates a dynamic programmatic transition and sets the latent/lytic balance during acute infection in trigeminal ganglia. PLoS Pathog 12:e1005877. https://doi.org/10.1371/journal.ppat.1005877
94. Hamza MA, Higgins DM, Ruyechan WT. 2006. Herpes simplex virus type-1 latency inhibits dendritic growth in sympathetic neurons. Neurobiol Dis 24:367-373. https://doi.org/10.1016/j.nbd.2006.07.011
95. Danaher RJ, McGarrell BS, Stromberg AJ, Miller CS. 2008. Herpes simplex virus type 1 modulates cellular gene expression during quiescent infection of neuronal cells. Arch Virol 153:1335-1345. https://doi.org/10.1007/s00705-008-0122-x
96. Roehm PC, Camarena V, Nayak S, Gardner JB, Wilson A, Mohr I, Chao MV. 2011. Cultured vestibular ganglion neurons demonstrate latent HSV1 reactivation. Laryngoscope 121:2268-2275. https://doi.org/10.1002/lary.22035
97. Mattila RK, Harila K, Kangas SM, Paavilainen H, Heape AM, Mohr IJ, Hukkanen V. 2015. An investigation of herpes simplex virus type 1 latency in a novel mouse dorsal root ganglion model suggests a role for ICP34.5 in reactivation. J Gen Virol 96:2304-2313. https://doi.org/10.1099/vir.0.000138
98. Pourchet A, Modrek A, Placantonakis D, Mohr I, Wilson A. 2017. Modeling HSV-1 latency in human embryonic stem cell-derived neurons. Pathogens 6:24. https://doi.org/10.3390/pathogens6020024
99. Macdonald SJ, Mostafa HH, Morrison LA, Davido DJ. 2012. Genome sequence of herpes simplex virus 1 strain McKrae. J Virol 86:9540-9541. https://doi.org/10.1128/JVI.01469-12
100. Bowen CD, Renner DW, Shreve JT, Tafuri Y, Payne KM, Dix RD, Kinchington PR, Gatherer D, Szpara ML. 2016. Viral forensic genomics reveals the relatedness of classic herpes simplex virus strains KOS, KOS63, and KOS79. Virology 492:179-186. https://doi.org/10.1016/j.virol.2016.02.013
101. Antinone SE, Smith GA. 2010. Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis. J Virol 84:1504-1512. https://doi.org/10.1128/JVI.02029-09
102. VanGuilder HD, Yan H, Farley JA, Sonntag WE, Freeman WM. 2010. Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome. J Neurochem 113:1577-1588
103. Galvan V, Brandimarti R, Roizman B. 1999. Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death. J Virol 73:3219-3226
104. Dingwell KS, Brunetti CR, Hendricks RL, Tang Q, Tang M, Rainbow AJ, Johnson DC. 1994. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol 68:834-845
105. Pasieka TJ, Lu B, Crosby SD, Wylie KM, Morrison LA, Alexander DE, Menachery VD, Leib DA. 2008. Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J Virol 82:5527-5535. https://doi.org/10.1128/JVI.02047-07
106. Nicola AV, Hou J, Major EO, Straus SE. 2005. Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pHdependent endocytic pathway. J Virol 79:7609-7616. https://doi.org/10.1128/JVI.79.12.7609-7616.2005
107. Kato A, Hirohata Y, Arii J, Kawaguchi Y. 2014. Phosphorylation of herpes simplex virus 1 dUTPase upregulated viral dUTPase activity to compensate for low cellular dUTPase activity for efficient viral replication. J Virol 88:7776-7785. https://doi.org/10.1128/JVI.00603-14
108. Galvan V, Roizman B. 1998. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc Natl Acad Sci U S A 95:3931-3936
109. Xiang Y, Zheng K, Ju H, Wang S, Pei Y, Ding W, Chen Z, Wang Q, Qiu X, Zhong M, Zeng F, Ren Z, Qian C, Liu G, Kitazato K, Wang Y. 2012. Cofilin 1-mediated biphasic F-actin dynamics of neuronal cells affect herpes simplex virus 1 infection and replication. J Virol 86:8440-8451. https://doi.org/10.1128/JVI.00609-12
110. Peng W, Henderson G, Inman M, BenMohamed L, Perng G-C, Wechsler SL, Jones C. 2005. The locus encompassing the latency-associated transcript of herpes simplex virus type 1 interferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal ganglia of acutely infected mice. J Virol 79:6162-6171. https://doi.org/10.1128/JVI.79.10.6162-6171.2005
111. Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED. 2005. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 79: 15226-15237. https://doi.org/10.1128/JVI.79.24.15226-15237.2005
112. Zhou G, Galvan V, Campadelli-Fiume G, Roizman B. 2000. Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J Virol 74:11782-11791. https://doi.org/10.1128/JVI.74.24.11782-11791.2000
113. Härle P, Sainz B, Carr DJ, Halford WP. 2002. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-α/β. Virology 293:295-304. https://doi.org/10.1006/viro.2001.1280
114. Lagunoff M, Randall G, Roizman B. 1996. Phenotypic properties of herpes simplex virus 1 containing a derepressed open reading frame P gene. J Virol 70:1810-1817
115. Snyder A, Wisner TW, Johnson DC. 2006. Herpes simplex virus capsids are transported in neuronal axons without an envelope containing the viral glycoproteins. J Virol 80:11165-11177. https://doi.org/10.1128/JVI.01107-06
116. Wisner TW, Sugimoto K, Howard PW, Kawaguchi Y, Johnson DC. 2011. Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J Virol 85:5919-5928. https://doi.org/10.1128/JVI.00116-11
117. Shinohara T, Nagashima K, Major EO. 1997. Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines. Virology 228: 269-277
118. Zhuo B, Wang R, Yin Y, Zhang H, Ma T, Liu F, Cao H, Shi Y. 2013. Adenovirus arming human IL-24 inhibits neuroblastoma cell proliferation in vitro and xenograft tumor growth in vivo. Tumor Biol 34: 2419-2426. https://doi.org/10.1007/s13277-013-0792-1
119. Jha HC, Mehta D, Lu J, El-Naccache D, Shukla SK, Kovacsics C, Kolson D, Robertson ES. 2015. Gammaherpesvirus infection of human neuronal cells. mBio 6:e01844-15. https://doi.org/10.1128/mBio.01844-15
120. Ahmed M, Lock M, Miller CG, Fraser NW. 2002. Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J Virol 76:717-729. https://doi.org/10.1128/JVI.76.2.717-729.2002
121. Kang W, Mukerjee R, Fraser NW. 2003. Establishment and maintenance of HSV latent infection is mediated through correct splicing of the LAT primary transcript. Virology 312:233-244. https://doi.org/10.1016/S0042-6822(03)00201-0
122. De Chiara G, Marcocci ME, Civitelli L, Argnani R, Piacentini R, Ripoli C, Manservigi R, Grassi C, Garaci E, Palamara AT. 2010. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 5:e13989. https://doi.org/10.1371/journal.pone.0013989
123. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgioua G, Fraser NW. 2006. Anti-apoptotic function of a microRNA encoded by the HSV-1 latencyassociated transcript. Nature 442:82-85
124. Thomas DL, Lock M, Zabolotny JM, Mohan BR, Fraser NW. 2002. The 2-kilobase intron of the herpes simplex virus type 1 latency-associated transcript has a half-life of approximately 24 hours in SY5Y and COS-1 cells. J Virol 76:532-540. https://doi.org/10.1128/JVI.76.2.532-540.2002
125. Xu K, Liu X-N, Zhang H-B, An N, Wang Y, Zhang Z-C, Wang Y-N. 2014. Replication-defective HSV-1 effectively targets trigeminal ganglion and inhibits viral pathopoiesis by mediating interferon gamma expression in SH-SY5Y cells. J Mol Neurosci 53:78-86. https://doi.org/10.1007/s12031-013-0199-x
126. Cho H-J, Song MJ. 2014. A gammaherpesvirus establishes persistent infection in neuroblastoma cells. Mol Cells 37:518-525. https://doi.org/10.14348/molcells.2014.0024
127. Thunuguntla P, El-mayet FS, Jones C. 2017. Bovine herpesvirus 1 can efficiently infect the human (SH-SY5Y) but not the mouse neuroblastoma cell line (Neuro-2A). Virus Res 232:1-5. https://doi.org/10.1016/j.virusres.2017.01.011
128. Christensen J, Steain M, Slobedman B, Abendroth A. 2013. Varicellazoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures. J Virol 87:13719-13728. https://doi.org/10.1128/JVI.02293-13
129. Carbone KM, Rubin SA, Sierra-Honigmann AM, Lederman HM. 1993. Characterization of a glial cell line persistently infected with Borna disease virus (BDV): influence of neurotrophic factors on BDV protein and RNA expression. J Virol 67:1453-1460
130. Jan J-T, Chen B-H, Ma S-H, Liu C-I, Tsai H-P, Wu H-C, Jiang S-Y, Yang K-D, Shaio M-F. 2000. Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-κB are sequentially involved. J Virol 74:8680-8691. https://doi.org/10.1128/JVI.74.18.8680-8691.2000
131. Tung W-H, Hsieh H-L, Lee I-T, Yang C-M. 2011. Enterovirus 71 induces integrin β1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: role of HO-1/CO in viral replication. J Cell Physiol 226:3316-3329. https://doi.org/10.1002/jcp.22677
132. Takamatsu Y, Uchida L, Morita K. 2015. Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus in human neuroblastoma and glioblastoma cells. J Gen Virol 96: 2194-2199. https://doi.org/10.1099/vir.0.000168
133. Dou J, Daly J, Yuan Z, Jing T, Solomon T. 2009. Bacterial cell surface display: a method for studying Japanese encephalitis virus pathogenicity. Jpn J Infect Dis 62:402-408
134. Zhang S-C, Cai W-S, Zhang Y, Jiang K-L, Zhang K-R, Wang W-L. 2012. Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human neuroblastoma through a CD46 and nectin 4-independent pathway. Cancer Lett 325:227-237. https://doi.org/10.1016/j.canlet.2012.07.008
135. Shingai M. 2003. Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis. J Gen Virol 84:2133-2143. https://doi.org/10.1099/vir.0.19091-0
136. Ishida H, Ayata M, Shingai M, Matsunaga I, Seto Y, Katayama Y, Iritani N, Seya T, Yanagi Y, Matsuoka O, Yamano T, Ogura H. 2004. Infection of different cell lines of neural origin with subacute sclerosing panencephalitis (SSPE) virus. Microbiol Immunol 48:277-287. https://doi.org/10.1111/j.1348-0421.2004.tb03524.x
137. Shimada S, Aoki K, Nabeshima T, Fuxun Y, Kurosaki Y, Shiogama K, Onouchi T, Sakaguchi M, Fuchigami T, Ono H, Nishi K, Posadas-Herrera G, Uchida L, Takamatsu Y, Yasuda J, Tsutsumi Y, Fujita H, Morita K, Hayasaka D. 2016. Tofla virus: a newly identified Nairovirus of the Crimean-Congo hemorrhagic fever group isolated from ticks in Japan. Sci Rep 6:20213. https://doi.org/10.1038/srep20213
138. Laassri M, Bidzhieva B, Speicher J, Pletnev AG, Chumakov K. 2011. Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virus. J Med Virol 83:910-920. https://doi.org/10.1002/jmv.22033
139. Xu L-J, Jiang T, Zhang F-J, Han J-F, Liu J, Zhao H, Li X-F, Liu R-J, Deng Y-Q, Wu X-Y, Zhu S-Y, Qin E-D, Qin C-F. 2013. Global transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infection. PLoS One 8:e65948. https://doi.org/10.1371/journal.pone.0065948
140. Du X, Wang H, Xu F, Huang Y, Liu Z, Liu T. 2015. Enterovirus 71 induces apoptosis of SH-SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Mol Med Rep 12:953-959. https://doi.org/10.3892/mmr.2015.3482
141. Bardi G, Sengupta R, Khan MZ, Patel JP, Meucci O. 2006. Human immunodeficiency virus gp120-induced apoptosis of human neuroblastoma cells in the absence of CXCR4 internalization. J Neurovirol 12:211-218. https://doi.org/10.1080/13550280600848373
142. Khan MB, Lang MJ, Huang M-B, Raymond A, Bond VC, Shiramizu B, Powell MD. 2016. Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Aβ1-42 secretion in SH-SY5Y neural cells. J Neurovirol 22:179-190. https://doi.org/10.1007/s13365-015-0383-6
143. Hu L, Uzhameckis D, Hedborg F, Blomberg J. 2016. Dynamic and selective HERV RNA expression in neuroblastoma cells subjected to variation in oxygen tension and demethylation. APMIS 124:140-149. https://doi.org/10.1111/apm.12494
144. Song B-H, Yun G-N, Kim J-K, Yun S-I, Lee Y-M. 2012. Biological and genetic properties of SA14-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans. J Microbiol 50: 698-706. https://doi.org/10.1007/s12275-012-2336-6
145. Kim J-M, Yun S-I, Song B-H, Hahn Y-S, Lee C-H, Oh H-W, Lee Y-M. 2008. A single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice. J Virol 82:7846-7862. https://doi.org/10.1128/JVI.00789-08
146. Sacramento CQ, de Melo GR, de Freitas CS, Rocha N, Hoelz LVB, Miranda M, Fintelman-Rodrigues N, Marttorelli A, Ferreira AC, Barbosa-Lima G, Abrantes JL, Vieira YR, Bastos MM, de Mello Volotão E, Nunes EP, Tschoeke DA, Leomil L, Loiola EC, Trindade P, Rehen SK, Bozza FA, Bozza PT, Boechat N, Thompson FL, de Filippis AMB, Brüning K, Souza TML. 2017. The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication. Sci Rep 7:40920. https://doi.org/10.1038/srep40920
147. Dhanwani R, Khan M, Bhaskar ASB, Singh R, Patro IK, Rao PVL, Parida MM. 2012. Characterization of Chikungunya virus infection in human neuroblastoma SH-SY5Y cells: role of apoptosis in neuronal cell death. Virus Res 163:563-572. https://doi.org/10.1016/j.virusres.2011.12.009
148. Huang H-I, Chang Y-Y, Lin J-Y, Kuo R-L, Liu H-P, Shih S-R, Wu C-C. 2016 Interactome analysis of the EV71 5= untranslated region in differentiated neuronal cells SH-SY5Y and regulatory role of FBP3 in viral replication. Proteomics 16:2351-2362. https://doi.org/10.1002/pmic.201600098
149. Vesanen M, Salminen M, Wessman M, Lankinen H, Sistonen P, Vaheri A. 1994 Morphological differentiation of human SH-SY5Y neuroblastoma cells inhibits human immunodeficiency virus type 1 infection. J Gen Virol 75:201-206
150. Recio JA, Martinez de la Mata J, Martin-Nieto J, Aranda A. 2000. Retinoic acid stimulates HIV-1 transcription in human neuroblastoma SH-SY5Y cells. FEBS Lett 469:118-122. https://doi.org/10.1016/S0014-5793 (00)01249-7
151. Zhu X, Yao H, Peng F, Callen S, Buch S. 2009. PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium. Toxicol Appl Pharmacol 240: 286-291. https://doi.org/10.1016/j.taap.2009.06.020
152. Peng F, Yao H, Akturk HK, Buch S. 2012. Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta. PLoS One 7:e47572. https://doi.org/10.1371/journal.pone.0047572
153. Yaiw KC, Hyatt A, VanDriel R, Crameri SG, Eaton B, Wong MH, Wang LF, Ng ML, Bingham J, Shamala D, Wong KT. 2008. Viral morphogenesis and morphological changes in human neuronal cells following Tioman and Menangle virus infection. Arch Virol 153:865-875. https://doi.org/10.1007/s00705-008-0059-0
154. Préhaud C, Lay S, Dietzschold B, Lafon M. 2003. Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. J Virol 77:10537-10547. https://doi.org/10.1128/JVI.77.19.10537-10547.2003
155. Préhaud C, Wolff N, Terrien E, Lafage M, Megret F, Babault N, Cordier F, Tan GS, Maitrepierre E, Menager P, Chopy D, Hoos S, England P, Delepierre M, Schnell MJ, Buc H, Lafon M. 2010. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci Signal 3:ra5. https://doi.org/10.1126/scisignal.2000510
156. Takenouchi A, Saito K, Saito E, Saito T, Hishiki T, Matsunaga T, Isegawa N, Yoshida H, Ohnuma N, Shirasawa H. 2015. Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain. Pediatr Surg Int 31:1151-1159. https://doi.org/10.1007/s00383-015-3784-y
157. Zhang X, Zheng Z, Shu B, Mao P, Bai B, Hu Q, Cui Z, Wang H. 2016. Isolation and characterization of a Far-Eastern strain of tick-borne encephalitis virus in China. Virus Res 213:6-10. https://doi.org/10.1016/j.virusres.2015.11.006
158. Ninomiya K, Kanayama T, Fujieda N, Nakayama T, Komase K, Nagata K, Takeuchi K. 2009. Amino acid substitution at position 464 in the haemagglutinin-neuraminidase protein of a mumps virus Urabe strain enhanced the virus growth in neuroblastoma SH-SY5Y cells. Vaccine 27:6160-6165. https://doi.org/10.1016/j.vaccine.2009.08.020
159. Elankumaran S, Rockemann D, Samal SK. 2006. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol 80:7522-7534. https://doi.org/10.1128/JVI.00241-06
160. Chen X, Quan R, Guo X, Gao L, Shi J, Feng W. 2014. Up-regulation of pro-inflammatory factors by HP-PRRSV infection in microglia: implications for HP-PRRSV neuropathogenesis. Vet Microbiol 170:48-57. https://doi.org/10.1016/j.vetmic.2014.01.031
161. Temonen M, Vapalahti O, Holthöfer H, Brummer-Korvenkontio M, Vaheri A, Lankinen H. 1993. Susceptibility of human cells to Puumala virus infection. J Gen Virol 74:515-518
162. Kim GN, Wu K, Hong JP, Awamleh Z, Kang CY. 2015. Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors. J Virol 89:6338-6351. https://doi.org/10.1128/JVI.00222-15
163. Maldonado H, Ortiz-Riaño E, Krause B, Barriga A, Medina F, Pando ME, Alberti C, Kettlun AM, Collados L, García L, Cartier L, Valenzuela MA. 2008. Microtubule proteins and their post-translational forms in the cerebrospinal fluid of patients with paraparesis associated with HTLV-I infection and in SH-SY5Y cells: an in vitro model of HTLV-Iinduced disease. Biol Res 41:239-259. https://doi.org/10.4067/S0716-97602008000300001